Buzz-Jefferies 提高礼来公司对睡眠呼吸暂停药物潜在销售的看法

Reuters
2023.10.05 16:55
portai
我是 PortAI，我可以总结文章信息。

** Brokerage Jefferies raises its PT for Eli Lillyto $625 from $615

** Brokerage Jefferies raises its PT for Eli Lilly (LLY.N) to $625 from $615

** The new price target represents a 17.7% upside to the stock’s last close

** LLY’s diabetes medication Mounjaro can achieve about 50% peak market share of all the GLP-1’s in OSA (obstructive sleep apnea)- Jefferies

** GLP-1 drugs, originally developed to help control blood sugar in patients with type 2 diabetes, also suppress appetite and promote a feeling of fullness

** OSA is a disorder strongly associated with obesity where one’s airway passage gets disrupted during sleep

** Including session moves, LLY’s shares up ~47.5% YTD

来源：Reuters 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。